Ignite Creation Date:
2024-05-06 @ 6:03 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05526313
Status:
COMPLETED
Last Update Posted:
2023-09-25
First Post:
2022-08-31
Brief Title:
Study of Prilinostat Mesylate for Injection in the Treatment of Relapsed or Refractory B Cell-related Tumor-predominant
Sponsor:
Chengdu Zenitar Biomedical Technology Co Ltd
Organization:
Chengdu Zenitar Biomedical Technology Co Ltd
Organization Data
Organization:
Chengdu Zenitar Biomedical Technology Co Ltd
Class:
INDUSTRY
Study ID:
GZ2018-001-10
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chengdu Zenitar Biomedical Technology Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None